CVS Caremark settles pharmacy underpayment allegations for $5M, reimbursing Oklahoma pharmacies for 68,099 prescriptions filled from 2024 to 2025.

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...

For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that ...

On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying ...

Birmingham, Alabama, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Curaechoice, the nation’s #1 leader in No-Cost Benefits Optimization Solutions, announced today that it has selected CVS Caremark at its pharmacy ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug for ...

When I walked into Zepbound’s Changing the Threads exhibit in New York City, the first thing I noticed were the clothes suspended around the space. And no, I wasn’t paying much attention to the ...

Zepbound’s Changing the Threads exhibit in Manhattan’s uber-chic Soho area was unlike anything I’d seen before. As soon as I stepped inside, I was greeted with a flood of green lights and projections.

CVS's pharmacy benefit manager, Caremark, is accused of driving independent pharmacies out of business and inflating drug costs. Federal agencies and judges have found CVS at fault for fraudulent ...

CVS Caremark commercial members receive access to accurate and confident blood glucose testing Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are ...

The White House unveiled agreements with pharma giants Eli Lilly and Company and Novo Nordisk to offer GLP-1's Zepbound, orforglipron, Ozempic and Wegovy through the prescription digital marketplace ...